Results 141 to 150 of about 35,686 (231)

Paraneoplastic retinopathy associated with retroperitoneal liposarcoma

, 2010
Mineo Kondo1, Kumiko Mokuno2, Ai Uemura1, Shu Kachi1, Makoto Nakamura1, Atsuya Kondo3, Hiroko Terasaki11Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 2Department of Ophthalmology, 3Department of Urology ...
Kumiko Mokuno, et al, Mineo Kondo, Ai Uemura   +3 more
core  

Characteristics and Outcomes of Patients With Dedifferentiated Liposarcoma in a US Community Setting. [PDF]

Cancer Med
Butrynski JE, Nepal B, Hu C, Guo J, Han J, Herms L, Klein AB, Stanhope S, Stanley EL, Todoroff K, Conkling P.   +10 more
europepmc   +1 more source

Dedifferentiated liposarcoma originating in the prostate: a rare case report. [PDF]

Discov Oncol
Chen J, Xu G, Zhang L, Liu J, Li Y, Zhao K, Peng C, Li M.   +7 more
europepmc   +1 more source

A Case Report: Retroperitoneal dedifferentiated liposarcoma with heterologous myogenic differentiation and testicular metastasis. [PDF]

Front Oncol
Ma H, Feng R, Zi G, Li Y, Xu Q, Ke C.
europepmc   +1 more source

Dedifferentiated Liposarcoma of the Epididymis: A Rare Case Report and Analysis [PDF]

Curr Med Imaging
Li A, Gao X, Wang Z, Li H, Cao Y.
europepmc   +1 more source

PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma. [PDF]

Sci Adv
Wilde BR, Klingbeil KD, Day F, Dann C, Frias C, Nakasaki M, Dry SM, Eilber FC, Crompton JG, Shackelford DB, Kadera BE, Christofk HR.   +11 more
europepmc   +1 more source

Dedifferentiated liposarcoma

, 2021
openaire   +1 more source

MDM2 and DDIT3 coexpression in dedifferentiated liposarcoma with myxoid features: a retrospective cohort study. [PDF]

Sci Rep
Ates KE, Gonlusen G, Erdogan S, Mirioglu A.   +3 more
europepmc   +1 more source

Dedifferentiated liposarcoma presenting with ascites as the initial clinical manifestation: a case report and literature review. [PDF]

Front Med (Lausanne)
Wang J, Chen L, He M, Yang M.
europepmc   +1 more source

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma. [PDF]

J Immunother Cancer
Rosenbaum E, Seier K, Gularte-Mérida R, Seffar E, Dickson MA, Avutu V, Banks LB, Chan JE, Chi P, Gounder MM, Kelly CM, Keohan ML, Maki RG, Movva S, Reed D, Desir R, Biniakewitz M, Cho JM, Duchemin M, Erinjeri JP, Lefkowitz RA, Koff A, Singer S, Tap W, Qin LX, D'Angelo S.   +25 more
europepmc   +1 more source